Trautec Medical Raises Nearly CNY 200 Mn in Series A Financing Round
Trautec Medical, dedicated to developing and producing recombinant collagen-based biomaterials, will continue to focus on the innovation of biomaterials and strive to integrate resources from all sides.
Yesterday 06:12 PM
Preparation Developer Elite Pharmaceutical Nets Nearly CNY 100 Mn in Series B Round
This financing round will further promote the company's R&D and clinical trials and be used to construct new production bases. The completion of the new production base will significantly improve the application efficiency of the products independently developed by Elite and reduce the cost without reducing the capacity of the products.
Yesterday 05:56 PM
WIM2022: Transcripts of Fireside Chat: China Globalization [2/2]
Yesterday 03:00 PM
WIM2022: Transcripts of Fireside Chat: China Globalization [1/2]
Yesterday 02:56 PM